NATIONWIDE CHILDREN'S HOSPITAL
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1892-01-01
- Employees
- 10K
- Market Cap
- -
Clinical Trials
225
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (162 trials with phase data)• Click on a phase to view related trials
Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
- Conditions
- High Grade Glioma (HGG) of the Brain With BRAF AberrationHigh Grade Glioma (III or IV)Diffuse Intrinsic Pontine GliomaHigh Grade GliomaWHO Grade 3 GliomaWHO Grade 4 GliomaMetastatic Brain Tumor
- Interventions
- First Posted Date
- 2025-10-03
- Last Posted Date
- 2025-10-29
- Lead Sponsor
- Nationwide Children's Hospital
- Target Recruit Count
- 79
- Registration Number
- NCT07206849
Pediatric Cochlear Implant Remote Programming and Assessment
- Conditions
- Cochlear Implant Listeners
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Nationwide Children's Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT07035873
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
Novel PIONEER© Protocol: RCT
- Conditions
- Deglutition Disorders in InfantsChronic Tube Feeding in Hospitalized Infants
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-11-21
- Lead Sponsor
- Nationwide Children's Hospital
- Target Recruit Count
- 134
- Registration Number
- NCT07035912
Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML
- Conditions
- Relapsed/Refractory AML
- Interventions
- Biological: Universal donor derived CD33 CAR-NK
- First Posted Date
- 2025-06-18
- Last Posted Date
- 2025-11-12
- Lead Sponsor
- Nationwide Children's Hospital
- Target Recruit Count
- 42
- Registration Number
- NCT07026942
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
Peripheral Regional Blockade and EMG
- Conditions
- Surgery
- First Posted Date
- 2025-05-21
- Last Posted Date
- 2025-10-30
- Lead Sponsor
- Nationwide Children's Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06982027
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 45
- Next
News
UC Davis Researchers Develop Gene Therapy to Reactivate Silent Genes in Rett Syndrome
UC Davis Health scientists led by Sanchita Bhatnagar have developed a novel gene therapy that reactivates silenced healthy genes in Rett syndrome by targeting microRNA-106a.
Cannabis Use During Pregnancy Linked to Tripled Risk of Behavioral Disorders in Children
New research reveals mothers who use cannabis during pregnancy are 3.5 times more likely to have children with disruptive behavioral disorders, including hostility and aggression.
Zolgensma's Journey: From $2M Charity-Funded Research to World's Most Expensive Drug
A breakthrough gene therapy for spinal muscular atrophy (SMA), initially funded by $2 million in charity and government grants, became the world's most expensive drug at $2.125 million per dose after corporate acquisition.